FANCG
Basic information
Region (hg38): 9:35073835-35080004
Previous symbols: [ "XRCC9" ]
Links
Phenotypes
GenCC
Source:
- Fanconi anemia complementation group G (Definitive), mode of inheritance: AR
- Fanconi anemia complementation group G (Strong), mode of inheritance: AR
- Fanconi anemia (Supportive), mode of inheritance: AR
- Fanconi anemia complementation group G (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Fanconi anemia, complementation group G | AR | Allergy/Immunology/Infectious; Cardiovascular; Hematologic; Oncologic | Specific treatments can help manifestations (eg, oral androgens for blood counts; G-CSF for neutrophil count); HSCT can be curative, but solid tumor risk may remain; Surveillance for complications such as bone marrow failure is recommended; Fanconi anemia can involve congenital cardiac (and other) anomalies, and awareness may allow early management | Audiologic/Otolaryngologic; Allergy/Immunology/Infectious; Cardiovascular; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic; Renal | 9806548; 20301575 |
ClinVar
This is a list of variants' phenotypes submitted to
- Fanconi anemia (68 variants)
- Fanconi anemia complementation group G (31 variants)
- not provided (9 variants)
- FANCG-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FANCG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 252 | 260 | ||||
missense | 204 | 216 | ||||
nonsense | 29 | 19 | 48 | |||
start loss | 0 | |||||
frameshift | 39 | 35 | 77 | |||
inframe indel | 7 | |||||
splice donor/acceptor (+/-2bp) | 31 | 38 | ||||
splice region | 1 | 18 | 52 | 1 | 72 | |
non coding | 15 | 122 | 12 | 149 | ||
Total | 75 | 91 | 236 | 379 | 14 |
Highest pathogenic variant AF is 0.0000791
Variants in FANCG
This is a list of pathogenic ClinVar variants found in the FANCG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-35073858-G-A | Fanconi anemia complementation group G | Uncertain significance (Jan 13, 2018) | ||
9-35073967-T-C | Fanconi anemia complementation group G | Uncertain significance (Jan 12, 2018) | ||
9-35074007-T-C | Fanconi anemia complementation group G | Uncertain significance (Jan 12, 2018) | ||
9-35074031-G-A | Fanconi anemia complementation group G | Uncertain significance (Apr 27, 2017) | ||
9-35074101-G-A | FANCG-related disorder | Likely benign (Apr 27, 2023) | ||
9-35074112-A-G | not specified | Uncertain significance (Feb 14, 2020) | ||
9-35074113-G-A | Fanconi anemia | Likely benign (Apr 28, 2022) | ||
9-35074114-G-A | Fanconi anemia | Likely benign (Dec 30, 2023) | ||
9-35074123-CTT-C | not specified • Fanconi anemia • Fanconi anemia complementation group G | Uncertain significance (Aug 10, 2022) | ||
9-35074126-T-C | Fanconi anemia | Likely benign (Sep 15, 2021) | ||
9-35074131-G-A | Fanconi anemia | Likely benign (May 15, 2023) | ||
9-35074139-C-T | Uncertain significance (Jul 05, 2019) | |||
9-35074140-G-A | Fanconi anemia | Uncertain significance (Aug 24, 2021) | ||
9-35074151-AG-A | Fanconi anemia | Uncertain significance (Jul 30, 2022) | ||
9-35074157-G-T | Fanconi anemia | Uncertain significance (Jan 25, 2024) | ||
9-35074159-G-A | Fanconi anemia • Fanconi anemia complementation group G | Likely benign (Dec 01, 2023) | ||
9-35074162-A-G | Fanconi anemia | Likely benign (Sep 27, 2023) | ||
9-35074163-C-T | Fanconi anemia • Fanconi anemia complementation group G • Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
9-35074164-G-A | Fanconi anemia complementation group G | Uncertain significance (Jul 18, 2022) | ||
9-35074167-C-G | Fanconi anemia | Uncertain significance (Mar 24, 2022) | ||
9-35074169-G-A | Fanconi anemia • Fanconi anemia complementation group G | Conflicting classifications of pathogenicity (Jan 18, 2024) | ||
9-35074171-G-A | Fanconi anemia | Likely benign (Sep 17, 2023) | ||
9-35074172-G-T | Fanconi anemia | Uncertain significance (Apr 18, 2019) | ||
9-35074172-GGACGGATCCA-G | Fanconi anemia complementation group G • Fanconi anemia • FANCG-related disorder | Pathogenic (Mar 25, 2024) | ||
9-35074173-G-A | Fanconi anemia | Uncertain significance (Sep 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FANCG | protein_coding | protein_coding | ENST00000378643 | 14 | 6182 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.49e-14 | 0.225 | 125638 | 0 | 110 | 125748 | 0.000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.245 | 301 | 313 | 0.961 | 0.0000182 | 3934 |
Missense in Polyphen | 83 | 84.734 | 0.97954 | 1149 | ||
Synonymous | 0.00585 | 138 | 138 | 0.999 | 0.00000740 | 1348 |
Loss of Function | 1.15 | 25 | 32.0 | 0.781 | 0.00000151 | 366 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000667 | 0.000658 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.000194 | 0.000185 |
European (Non-Finnish) | 0.000596 | 0.000580 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.000393 | 0.000392 |
Other | 0.000663 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Candidate tumor suppressor gene.;
- Pathway
- Fanconi anemia pathway - Homo sapiens (human);Retinoblastoma (RB) in Cancer;Fanconi Anemia Pathway;DNA Repair;role of brca1 brca2 and atr in cancer susceptibility;brca1 dependent ub ligase activity;Fanconi anemia pathway;BARD1 signaling events
(Consensus)
Recessive Scores
- pRec
- 0.406
Intolerance Scores
- loftool
- 0.873
- rvis_EVS
- 0.78
- rvis_percentile_EVS
- 87.14
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.518
- ghis
- 0.497
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.767
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fancg
- Phenotype
- reproductive system phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- ovarian follicle development;DNA repair;mitochondrion organization;spermatid development;response to radiation;interstrand cross-link repair
- Cellular component
- nucleoplasm;nucleolus;mitochondrion;cytosol;plasma membrane;Fanconi anaemia nuclear complex
- Molecular function
- damaged DNA binding;protein binding